Summary & Overview
CPT 82672: Total Estrogens, Hormone Assay
CPT code 82672 denotes a laboratory assay for total estrogens, a measure used to assess overall estrogen status in men and women. Nationally, this test supports evaluation of endocrine function, reproductive health, and certain oncologic assessments, making it relevant across outpatient and hospital laboratory settings. The code matters for payers and providers because estrogen measurement informs diagnostic pathways and can affect downstream care decisions and utilization.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer coverage considerations. The publication outlines common billing practice points, typical modifier usage (provided in the input), and where CPT code 82672 fits within laboratory service lines.
This summary also prepares readers for benchmarks and policy updates relevant to laboratory hormone testing, explains common clinical indications for ordering total estrogen testing, and identifies gaps where input data are not provided. Data not available in the input include specific payer reimbursement rates, associated taxonomies, ICD-10 diagnosis mappings, and related billing codes.
Billing Code Overview
CPT code 82672 measures total estrogens, providing an overall picture of estrogen status in both men and women. The test quantifies circulating estrogen levels to inform evaluation of hormonal status, endocrine disorders, fertility assessments, and certain tumor markers.
Service Type: Clinical laboratory — hormone assay
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is a reproductive-age woman or an adult male referred for endocrine evaluation when an overall assessment of estrogen status is needed. Indications include investigation of menstrual irregularities, amenorrhea, infertility workup, polycystic ovary syndrome monitoring, suspicion of estrogen-producing tumors, evaluation of menopausal status, gynecology preoperative assessment, or evaluation of hypogonadism in men. The clinical workflow begins with the ordering clinician (e.g., primary care physician, gynecologist, reproductive endocrinologist, or endocrinologist) placing an order for 82672 (total estrogens) in the electronic health record. The patient presents to an outpatient laboratory, hospital phlebotomy, or ambulatory surgery center for venipuncture; typical site of service is an outpatient laboratory or hospital outpatient phlebotomy unit. A blood specimen is collected, labeled, and transported to the clinical laboratory where the laboratory analyst performs the assay to measure total estrogens. Results are reported back to the ordering provider and integrated into the patient’s chart to guide diagnosis and management decisions such as further endocrine testing, imaging, or therapeutic planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation component if the laboratory splits technical and professional components. |